NEW CRYSTALLINE POLYMORPHIC FORM OF PSILOCIN

A crystalline polymorphic form of psilocin is disclosed. The beneficial and therapeutic uses of the crystalline form and of compositions containing the crystalline form are also disclosed. The disclosure sets out methods of making and characterizing the crystalline form. L'invention concerne un...

Full description

Saved in:
Bibliographic Details
Main Authors HOUSTON, Travis Lee, PARENT, Stephan D, SCHULTHEISS, Nate
Format Patent
LanguageEnglish
French
Published 10.11.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A crystalline polymorphic form of psilocin is disclosed. The beneficial and therapeutic uses of the crystalline form and of compositions containing the crystalline form are also disclosed. The disclosure sets out methods of making and characterizing the crystalline form. L'invention concerne une forme polymorphe cristalline de psilocine. L'invention concerne également les utilisations bénéfiques et thérapeutiques de la forme cristalline et de compositions contenant la forme cristalline. L'invention concerne des procédés de fabrication et de caractérisation de la forme cristalline.
Bibliography:Application Number: WO2022US27843